Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Cancers of the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04634825
What this trial is testing

Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck NeoplasmsHead and Neck Squamous Cell Carcinoma
MacroGenics 62
Early research (Phase 1)Looking for participantsNCT05859074
What this trial is testing

MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more
Memorial Sloan Kettering Cancer Center 56
Testing effectiveness (Phase 2)Study completedNCT00188318
What this trial is testing

Hardwins - Squamous Cell Carcinoma Head & Neck (Surgery/RT)

Who this might be right for
Carcinoma, Squamous Cell
University Health Network, Toronto 169
Testing effectiveness (Phase 2)Study completedNCT01057589
What this trial is testing

Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
Eli Lilly and Company 66
Not applicableStudy completedNCT03268993
What this trial is testing

Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell Carcinoma (HNSCC)Head and Neck Carcinoma+6 more
University of Pittsburgh 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07128693
What this trial is testing

A Single-center, Multicohort, Phase II Clinical Study Evaluating the Combination Therapy of Sacituzumab Tirumotecan in Patients With Unresectable, Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 60
Testing effectiveness (Phase 2)UnknownNCT04277858
What this trial is testing

Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.

Who this might be right for
Oropharynx CancerTonsil CancerThroat Cancer+1 more
Nader Sadeghi 60
Testing effectiveness (Phase 2)Ended earlyNCT03522584
What this trial is testing

Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
University of Washington 6
Early research (Phase 1)Study completedNCT04354246
What this trial is testing

COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

Who this might be right for
Advanced CancerOvarian CancerLung Cancer+6 more
Compugen Ltd 94
Not applicableStudy completedNCT05941676
What this trial is testing

Prognostic Immune Biomarkers in HNSCC

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma
University Hospital Ostrava 55
Large-scale testing (Phase 3)Study completedNCT00002727
What this trial is testing

Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord

Who this might be right for
Head and Neck Cancer
Radiation Therapy Oncology Group 250
Early research (Phase 1)Ended earlyNCT06285097
What this trial is testing

PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors

Who this might be right for
NeoplasmsNon-small-cell Lung CancerMelanoma+5 more
Pfizer 9
Large-scale testing (Phase 3)Not Yet RecruitingNCT07251062
What this trial is testing

SYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma.

Who this might be right for
Esophageal Squamous Cell Carcinoma
CSPC Megalith Biopharmaceutical Co.,Ltd. 737
Testing effectiveness (Phase 2)Study completedNCT00791141
What this trial is testing

Adjuvant Cetuximab and Chemoradiation in Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Heinrich-Heine University, Duesseldorf 80
Testing effectiveness (Phase 2)Study completedNCT00019331
What this trial is testing

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Who this might be right for
Colorectal CancerEndometrial CancerHead and Neck Cancer+6 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT06380686
What this trial is testing

Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome

Who this might be right for
Squamous Cell Carcinoma of the Oral CavitySquamous Cell Carcinoma of the OropharynxSquamous Cell Carcinoma of the Hypopharynx+1 more
AIO-Studien-gGmbH 120
Not applicableEnded earlyNCT05061940
What this trial is testing

This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.

Who this might be right for
Head and Neck CancerMelanomaHPV-Related Malignancy+5 more
Repertoire Immune Medicines 22
Not applicableStudy completedNCT05123950
What this trial is testing

Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Bristol-Myers Squibb 304
Testing effectiveness (Phase 2)UnknownNCT05636150
What this trial is testing

A Phase II Clinical Study of Fruquintinib Combined With S-1 for Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking Union Medical College Hospital 48
Not applicableLooking for participantsNCT05808920
What this trial is testing

The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Royal Marsden NHS Foundation Trust 400
Next Page